CA125 is the gold standard tumor marker in ovarian cancer. Serum level of CA125 is used to monitor response to chemotherapy, relapse, and disease progression in ovarian cancer patients. Thus, it is reasonable to investigate whether CA125 may have utility
Survival and Molecular Marker Differences Between Women Over and Under 45 Years of Age With Advanced Ovarian CancerAn abstract is unavailable.ChanJ. KLoizziMagistrisLinRutgers
The five-year cancer-specific survival rate with either surgical or radiation treatment is at least 95%. Recognizing the outstanding cure rates with RT alone in stage IA cervical cancer, combined with the fact that irradiation is typically used in lieu of primary surgery in such early-stage ...
To guard against systematic contamination of PCR reagent, appropriate positive (HPV-16–positive cervical cancer) and negative (deionized water and PCR master mix without template) controls were included in each step of the PCR process. Genotypes of HPV were determined by sequencing.5 Real-time ...
The difference in incidence of oral cavity cancer (OCC) between both the Netherlands and Taiwan is striking. Taiwan has one of the world’s highest incidence rates of OCC1. In 2016, 5116 patients were diagnosed with OCC with a standardized incidence rate of 13.8 cases per 100,000 population...
of death (or excess mortality) is a measure of the mortality due to cancer over and above the expected mortality, defined earlier. In contrast with survival, a cumulative measure, the hazard is an instantaneous measure and therefore detects any changes in the rate at which excess or cancer-...
In KEYNOTE-826, when KEYTRUDA was administered in combination with paclitaxel and cisplatin or paclitaxel and carboplatin, with or without bevacizumab (n=307), to patients with persistent, recurrent, or first-line metastatic cervi...
Purpose: The impact of tramadol analgesic use before breast cancer diagnosis on survival in patients with chronic pain is unclear. Therefore, we designed a propensity score-matched population-based cohort study to compare the breast cancer-related surviv
EGFR-genes; drug therapy; lung cancer; metastasis; survival analysis; TKI1. Introduction In 2020, lung cancer was still the leading cancer worldwide in terms of mortality. NSCLC accounts for nearly 85% of these cancers [1]. In the era of conventional cytotoxic drugs, the prognosis for this...
To generate data on the nature and duration of cervical cancer symptoms, risk factors for delayed consultation, and diagnosis of adolescent and young adult groups in Côte d'Ivoire. Thi